Clinical Trial Update: Endothelial Cell Loss After Cataract Surgery [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial assessing endothelial cell loss after cataract surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataracts

Snippet

Sponsor: University of California, San Francisco | Conditions: Cataracts | Phase 2, Phase 3 | Status: TERMINATED